黑色素瘤特异性基因网络分析提示MZB1为潜在促癌因子
研究利用人黑色素瘤样本数据集开展黑色素瘤特异性免疫调节基因网络分析,筛出5个显著影响患者生存的差异表达免疫相关基因;经人黑色素瘤组织芯片免疫组化分析,MZB1是与黑色素瘤进展关联最强的候选基因。人黑色素瘤细胞系中敲低MZB1可降低体外增殖并减少体内异种移植瘤生长;结合NanoString nCounter谱分析与Ingenuity Pathway Analysis,发现MZB1敲低调控包括细胞因子与II类HLA成员在内的多类基因表达。
要点
- MZB1是与黑色素瘤进展关联最强的候选免疫相关基因。
- 敲低MZB1可降低黑色素瘤细胞体外增殖与体内异种移植瘤生长。
- MZB1敲低调控细胞因子及II类HLA等基因,提示免疫相关机制。
核心结论
- MZB1是黑色素瘤的潜在促癌因子,可作为黑色素瘤管理的候选靶点。
研究设计与样本
- 基于人黑色素瘤样本数据集进行黑色素瘤特异性免疫调节基因网络分析。
- 采用人黑色素瘤组织芯片免疫组化分析评估候选基因与进展的关联。
- 在人黑色素瘤细胞系中行MZB1敲低,评估体外增殖与体内异种移植瘤生长。
- 对MZB1敲低黑色素瘤细胞行NanoString nCounter谱分析并结合Ingenuity Pathway Analysis。
主要发现
- 鉴定出5个显著影响黑色素瘤患者生存的差异表达免疫相关基因。
- 免疫组化分析显示MZB1是与黑色素瘤进展关联最强的候选基因。
- MZB1敲低降低人黑色素瘤细胞系体外增殖并减少体内异种移植瘤生长。
- MZB1敲低调控细胞因子与II类HLA成员等多类基因的表达。
临床怎么用
- MZB1值得作为黑色素瘤潜在治疗靶点进一步探索,但尚需临床前与临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Resistance to targeted therapy and immunotherapy is a major barrier to successful metastatic melanoma treatment. Interestingly, many genes can govern melanoma cell proliferation and progression mechanisms while simultaneously modulating the tumor microenvironment and tumor immunity. Using human melanoma sample datasets, we performed a melanoma-specific immunoregulatory gene network analysis and identified 5 differentially expressed immune-related genes that significantly affect the survival of patients with melanoma. Through immunohistochemistry analysis of human melanoma tissue microarray, we found that MZB1 was the strongest candidate associated with melanoma progression. We further found that MZB1 knockdown in human melanoma cell lines decreased proliferation in vitro and xenograft tumor growth in vivo. To determine immune-related mechanisms of MZB1, we coupled NanoString nCounter Profiling of MZB1-knockdown melanoma cells with Ingenuity Pathway Analysis. We identified that MZB1 knockdown modulated the expression of numerous gene classes, including cytokines and class II HLA members. Overall, our study shows that MZB1 is a potential tumor promoter in melanoma and could be explored as a target for melanoma management.
引用
- Chhabra G, Su S, Shirley CA, et al. A Melanoma-Specific Gene Network Analysis Identifies MZB1 as a Potential Tumor Promoter. J Invest Dermatol. 2025. PMID: 40749972. doi:10.1016/j.jid.2025.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。